Yes, you can—and should—get a second opinion on an Alzheimer’s diagnosis. One of the most unsettling discoveries in dementia research is how often the initial diagnosis is wrong. When researchers at the National Institute on Aging followed patients who had received clinical diagnoses of Alzheimer’s disease, they found that only 78.4% of those diagnoses were actually confirmed by neuropathological examination at autopsy. That means roughly 1 in 5 patients received an incorrect diagnosis. Consider the case of a 68-year-old woman whose primary care doctor diagnosed her with Alzheimer’s based on memory loss and cognitive decline.
Six months later, further testing revealed she actually had frontotemporal dementia—a different disease requiring different management. Without that second opinion, she would have been managed incorrectly for years. The high misdiagnosis rate isn’t due to incompetence; it reflects the genuine complexity of brain disease. Dementia looks similar under the surface but has many different causes, each requiring its own treatment approach. Because the stakes are high—an incorrect diagnosis can mean starting the wrong medications, missing reversible causes, or losing time with ineffective treatments—seeking a second opinion isn’t excessive caution. It’s standard practice.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why Alzheimer’s Misdiagnosis Is So Common
- How Alzheimer’s Disease Is Actually Diagnosed
- Conditions Mistaken for Alzheimer’s Disease
- Who Should Evaluate You and When to Seek a Specialist
- Blood Tests and Biomarkers: A New Diagnostic Tool
- Why Even Specialists Disagree: The Reality of Mixed Pathology
- Steps for Getting a Second Opinion
Why Alzheimer’s Misdiagnosis Is So Common
The misdiagnosis problem is larger than many people realize. When researchers analyzed patients evaluated at specialized Alzheimer’s disease centers, nearly 25% received either a false-positive diagnosis (being told they had Alzheimer’s when they didn’t) or a false-negative diagnosis (being told they didn’t have Alzheimer’s when they did). These were research centers staffed by dementia experts, not community clinics. Even specialists with access to advanced testing couldn’t perfectly distinguish Alzheimer’s from other conditions.
The most common reason for misdiagnosis tells an important story. Vascular pathology—damage to blood vessels in the brain—was the leading cause of false-positive diagnoses, meaning people were told they had Alzheimer’s when they actually had vascular dementia. Conversely, Lewy body dementia was the most commonly missed condition; patients with this disease were told they had Alzheimer’s, sometimes for years, before the correct diagnosis emerged. These aren’t rare edge cases. They happen frequently enough that neuropathology studies have documented the patterns clearly.
How Alzheimer’s Disease Is Actually Diagnosed
There is no single test for Alzheimer’s disease. This is a critical fact that distinguishes Alzheimer’s from many other medical conditions. Diagnosis requires a combination of clinical history, neuropsychological testing, neurological examination, brain imaging (MRI, CT, or PET scans), and laboratory tests designed to rule out other causes. A neuropsychologist might spend several hours testing your memory, language, reasoning, and executive function. Your doctor might order blood work to check your thyroid function, vitamin B12 levels, and other metabolic factors that can mimic dementia.
An MRI or PET scan provides pictures of what’s happening inside your brain. The specific cognitive tests used include the Mini Mental State Examination (MMSE), which screens for cognitive impairment; the Clinical Dementia Rating (CDR), which stages severity; the Functional Assessment Staging (FAST), which tracks how the disease affects daily activities; and the Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-cog), a more detailed test often used in research and specialist settings. Each test measures something slightly different, and together they build a picture of what kind of cognitive loss is occurring and how severe it is. The limitation of this multi-test approach is that it requires time, expertise, and coordination—elements that aren’t always available in a typical primary care office. A busy general practitioner might order an MRI and give you a screening cognitive test, but not the full neuropsychological battery or the comprehensive lab workup that a memory specialist would provide. The difference between an adequate evaluation and a thorough one can mean the difference between a correct diagnosis and a misdiagnosis.
Conditions Mistaken for Alzheimer’s Disease
Before assuming you have Alzheimer’s, it’s worth knowing that several other conditions can produce nearly identical symptoms. Depression is one of the most common culprits; it causes memory problems, slowed thinking, and cognitive fog that can look exactly like dementia. Vitamin B12 deficiency causes cognitive impairment that can be partially or fully reversible if caught and treated. Hypothyroidism (an underactive thyroid) slows metabolism and cognition. Untreated sleep apnea, where people stop breathing repeatedly during sleep, deprives the brain of oxygen and causes cognitive decline. Normal pressure hydrocephalus produces a distinctive triad of gait problems, incontinence, and dementia—but it can be treated with a shunt.
Medication side effects are another frequently overlooked cause; some blood pressure drugs, antihistamines, and psychiatric medications can impair cognition significantly. The research is stark on this point: 63% of patients clinically diagnosed with Alzheimer’s during life were found at autopsy to have mixed pathology—meaning they had Alzheimer’s disease plus at least one other type of brain pathology. This finding has major implications for second opinions. It means that even when an Alzheimer’s diagnosis is “correct,” it may be incomplete. A patient might have Alzheimer’s and vascular changes, or Alzheimer’s and Lewy bodies. Treating only for Alzheimer’s might miss the other pathology that’s also contributing to the person’s symptoms.
Who Should Evaluate You and When to Seek a Specialist
A primary care doctor can begin the dementia evaluation. They can take a history, order initial tests, and refer you onward. But certain situations warrant a more specialized evaluation from the start. If your symptoms are unusual or atypical—for instance, if you’re having trouble with movement or balance along with memory loss, or if you’re much younger than the typical Alzheimer’s patient—a neurologist should evaluate you. If symptoms are progressing rapidly, a specialist can help determine whether something more urgent is happening.
If the diagnosis remains unclear after the initial workup, or if you’ve been diagnosed but the standard treatments aren’t helping, that’s a strong signal to see a geriatrician, geriatric psychiatrist, or memory specialist. The practical approach is this: a second opinion from a memory specialist (a neurologist or geriatrician with additional fellowship training in dementia) brings several advantages. They’ve seen more cases, they’re more likely to order and interpret advanced testing, and they’re more attuned to uncommon presentations and diagnostic pitfalls. If you received your initial diagnosis from a primary care doctor or a general neurologist, seeing a memory specialist is often worthwhile. If you received it from a memory specialist at a university medical center but your condition isn’t responding as expected, seeking a second opinion from a different institution—preferably one with a research or autopsy program—can provide fresh perspective.
Blood Tests and Biomarkers: A New Diagnostic Tool
A significant development happened in May 2025 when the FDA cleared the first blood test specifically for Alzheimer’s disease diagnosis. Called the Lumipulse G test, it measures the ratio of plasma p-tau217 to amyloid-beta 1-42, two proteins associated with Alzheimer’s pathology. This test achieved 91.7% positive concordance and 97.3% negative concordance with PET imaging, meaning it accurately identified who had Alzheimer’s disease pathology in the brain. The 2024 revised diagnostic criteria from the National Institute on Aging and Alzheimer’s Association now endorse p-tau217 as the only plasma biomarker approved for Alzheimer’s diagnosis.
The appeal of a blood test is obvious: it’s simple, non-invasive, and potentially available through many clinics rather than just specialized centers. However—and this is crucial—blood biomarker tests should not be used alone to diagnose dementia. The results must be considered alongside clinical assessment, cognitive testing, imaging, and neuropsychological testing. A positive blood biomarker means you have Alzheimer’s pathology in your brain, but it doesn’t tell you whether that pathology is causing your symptoms or whether other conditions are contributing. In other words, a blood test can support a diagnosis, but it cannot replace the comprehensive evaluation that a specialist provides.
Why Even Specialists Disagree: The Reality of Mixed Pathology
One reason second opinions matter, even when they come from equally qualified specialists, is that the brain often contains multiple types of pathology simultaneously. The Alzheimer’s Association reports that nearly two-thirds of patients clinically diagnosed during life had mixed pathology at autopsy—perhaps Alzheimer’s changes plus vascular damage, or Alzheimer’s plus Lewy bodies, or all three. This complexity means that different specialists, evaluating the same patient with equally rigorous methods, might emphasize different aspects of the disease picture. A neurologist focused on movement disorders might weight Lewy body pathology more heavily in a patient with Parkinson-like symptoms.
A vascular specialist might emphasize cerebrovascular disease. A general dementia specialist might focus on the Alzheimer’s component. Each opinion would be defensible, yet they’d lead to somewhat different management approaches. This isn’t a flaw in the diagnostic system; it’s a reflection of how disease actually works in real brains.
Steps for Getting a Second Opinion
If you’re considering a second opinion, gather your records first: the original imaging (MRI or PET scans on disk, not just the report), copies of all cognitive testing results, lab work, and any specialist letters or reports. Bring these to your second opinion appointment. The new evaluator will want to see the full picture of what was done before rather than starting completely from scratch, though they’ll also do at least some re-evaluation to confirm findings.
Be specific about what prompted the second opinion. Are you questioning the diagnosis because it doesn’t fit your symptoms? Because treatments aren’t working? Because the disease is progressing faster or slower than expected? Or simply because you want reassurance? Each of these concerns points to different priorities in the re-evaluation. A specialist will want to know whether anything has changed since the first diagnosis, what medications you’re taking, and whether family members have noticed new symptoms. With this information, combined with whatever testing they deem necessary, they can provide their independent assessment—which may confirm the original diagnosis, modify it, or point toward a different condition altogether.
